Rivus Pharmaceuticals

Weight loss player gets attention of RA Capital, walks away with $132M to keep pursuing big targets
Endpoints
Thu, 09/22/22 - 10:16 am
Rivus Pharmaceuticals
funding
obesity
HU6
Taking on Big Pharma-sized indications, tiny biotech claims early win in fat loss. Will it translate to diabetes, NASH and beyond?
Endpoints
Wed, 02/9/22 - 10:01 am
Rivus Pharmaceuticals
diabetes
NASH
heart failure
Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases
Fierce Biotech
Tue, 07/20/21 - 12:27 pm
Rivus Pharmaceuticals
type 2 diabetes
NASH
hypertriglyceridemia
heart failure with preserved ejection fraction